Peo in Interest of Harris

CourtColorado Court of Appeals
DecidedOctober 30, 2025
Docket25CA1642
StatusUnpublished

This text of Peo in Interest of Harris (Peo in Interest of Harris) is published on Counsel Stack Legal Research, covering Colorado Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Peo in Interest of Harris, (Colo. Ct. App. 2025).

Opinion

25CA1642 Peo in Interest of Harris 10-30-2025

COLORADO COURT OF APPEALS

Court of Appeals No. 25CA1642 Mesa County District Court No. 25MH30128 Honorable Gretchen B. Larson, Judge

The People of the State of Colorado,

Petitioner-Appellee,

In the Interest of James Harris,

Respondent-Appellant.

ORDERS AFFIRMED

Division VI Opinion by JUSTICE MARTINEZ* Welling and Sullivan, JJ., concur

NOT PUBLISHED PURSUANT TO C.A.R. 35(e) Announced October 30, 2025

Todd M. Starr, County Attorney, Richard B. Tuttle, Assistant County Attorney, Brad Junge, Assistant County Attorney, Grand Junction, Colorado, for Petitioner-Appellee

Tezak Law, P.C., Mary Tezak, Florence, Colorado, for Respondent-Appellant

*Sitting by assignment of the Chief Justice under provisions of Colo. Const. art. VI, § 5(3), and § 24-51-1105, C.R.S. 2025. ¶1 Respondent, James Harris, appeals the district court’s orders

(1) certifying him for short-term treatment and (2) authorizing the

administration of medications to him without his consent. He

contends that the evidence was insufficient to sustain either order.

We disagree and therefore affirm.

I. Background

¶2 In late July 2025, Harris voluntarily sought treatment at a

hospital emergency room (the ER) and, due to his symptoms of

psychosis, was placed on an emergency mental health hold.

¶3 He was transferred to Centennial Peaks Hospital (the hospital)

for inpatient psychiatric care. His symptoms included responding

to internal stimuli, having conversations with people who were not

there, expressing delusional beliefs and disorganized thoughts, and

being manic and verbally aggressive. His psychiatrist at the

hospital diagnosed him with schizoaffective disorder.

¶4 The psychiatrist filed a notice of certification for short-term

treatment of Harris under section 27-65-109, C.R.S. 2025, along

with a request for authorization to administer to Harris several

antipsychotic medications, an antianxiety medication, and a

medication to treat any side effects.

1 ¶5 At the hearing, the psychiatrist and Harris both testified. The

psychiatrist, whom the parties stipulated was an expert in

psychiatry, testified that Harris’s schizoaffective disorder

constitutes a substantial disorder that grossly impairs his

judgment, his ability to recognize reality, and his ability to control

his behavior. In support of the short-term certification, the

psychiatrist opined, among other things, that Harris is gravely

disabled because he is incapable of making informed decisions

about or providing for his essential needs without significant

supervision and assistance from other people. In terms of

medications, the psychiatrist requested authorization to

involuntarily administer to Harris the following: (1) three

antipsychotic medications — Haldol (haloperidol), Prolixin

(fluphenazine), and Invega (paliperidone); (2) Ativan (lorazepam), an

antianxiety medication; and (3) Cogentin (benztropine), an as-

needed medication to treat any side effects. The psychiatrist opined

that the medications are “essential” to effectively treat Harris’s

mental health disorder, and that without treatment, “[h]e will

definitely continue to deteriorate.”

2 ¶6 The psychiatrist also testified that Harris does not possess any

insight into his mental health disorder, explaining that Harris has

expressed that he doesn’t need the medications because he doesn’t

have a mental illness. The psychiatrist testified that Harris has

been voluntarily taking one pill of the antipsychotic medication

Zyprexa (olanzapine) at night as a sleep aid. The psychiatrist

testified that Harris has only “improved slightly” taking the single

pill of Zyprexa, explaining that “there’s a slight improvement in

terms of mania and slight reduction of the aggressiveness.”

However, the psychiatrist testified that Harris has already

“plateaued” on the single pill of Zyprexa and remains gravely

disabled, explaining that the single pill of Zyprexa has not

addressed his psychosis, delusions, or hallucinations, and his

symptoms continue to be “very disruptive and severe.”

¶7 During Harris’s testimony, when he was asked whether he has

a mental illness, he responded, “I kind of do. . . . It’s called Juggalo

Clown syndrome. We’re almost like bipolar.” When he was asked

whether he has schizoaffective disorder, he responded, “I don’t

know. I don’t believe much of what they say.” However, Harris

repeatedly made clear during his testimony that he was only willing

3 to take the single pill of Zyprexa at night as a sleep aid, and that he

wants to be either immediately transferred to a different facility or

released so he can stay at his girlfriend’s house. As we explain in

more detail in our analysis below, he also testified regarding the

reasons he does not want to take the medications requested by the

psychiatrist.

¶8 Following the testimony, the district court found that the

psychiatrist’s testimony was “much more compelling and

persuasive” than Harris’s testimony. The court then certified Harris

for short-term treatment based on, among other findings, a finding

that Harris is gravely disabled as a result of his schizoaffective

disorder. See § 27-65-109(1)(a). Further, after analyzing the four

elements of the test from People v. Medina, 705 P.2d 961, 973 (Colo.

1985), the court also granted the request for authorization to

involuntarily administer the requested medications.

II. Standards of Review

¶9 On a challenge to the sufficiency of the evidence, we review the

record de novo to determine whether the evidence, viewed as a

whole and in the light most favorable to the State, is sufficient to

support the district court’s order. People in Interest of Ramsey,

4 2023 COA 95, ¶ 23. We review de novo the court’s conclusions of

law and defer to the court’s findings of fact if sufficient evidence in

the record supports them. Id. The resolution of conflicts in

testimony and determinations of witness credibility are solely within

the province of the fact finder. Id.

III. Certification for Short-Term Treatment

¶ 10 A person may be certified for up to three months of treatment

under section 27-65-109 if he has a mental health disorder and, as

a result of the disorder, (1) is a danger to himself or others or (2) is

gravely disabled. § 27-65-109(1)(a); Ramsey, ¶ 25. The State has

the burden of proving that by clear and convincing evidence, but a

psychiatrist’s testimony alone may be sufficient to do so. § 27-65-

113(1), C.R.S. 2025; Ramsey, ¶ 25; People v. Pflugbeil, 834 P.2d

843, 846-47 (Colo. App. 1992).

¶ 11 Again, the district court based the certification on its finding

that Harris is gravely disabled as a result of his schizoaffective

disorder. The statutory scheme defines “gravely disabled” as “a

condition in which a person, as a result of a mental health disorder,

is incapable of making informed decisions about or providing for the

5 person’s essential needs without significant supervision and

assistance from other people.” § 27-65-102(17), C.R.S.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. Medina
705 P.2d 961 (Supreme Court of Colorado, 1985)
People v. Pflugbeil
834 P.2d 843 (Colorado Court of Appeals, 1992)
People ex rel. R.K.L
2016 COA 84 (Colorado Court of Appeals, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
Peo in Interest of Harris, Counsel Stack Legal Research, https://law.counselstack.com/opinion/peo-in-interest-of-harris-coloctapp-2025.